HEAL logo

HEAL Global X HealthTech ETF

NASDAQ · Asset Management · Financial Services

$29.25
+0.07 (+0.22%)

HEAL aims to focus on tech-driven innovation in the healthcare sector. As such, the fund seeks to provide exposure to firms looking to shape the future of healthcare by improving patient outcomes and driving medical breakthroughs. Companies around the world, including ADRS, that engage in healthcare analytics and software, smart medical devices, AI-enabled drug discovery, and tech-enabled consumer…

Market Cap: $32.01Mwww.healwell.ai

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 11Aug 11

Quote

Day Range
$29.25 – $29.42
52-Week Range
$23.00 – $33.59
Volume
$2.4K
Market Cap
$32.01M
50-Day Avg
$27.36
200-Day Avg
$27.51
Prev Close
$29.18
Open
$29.38

Valuation & Ratios

P/E Ratio
EPS
P/B Ratio
P/S Ratio
Debt/Equity
Current Ratio
Dividend Yield
Gross Margin

Returns & Efficiency

Return on Equity
Return on Assets
FCF Yield
EV/EBITDA

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Valuation

HEALhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsnewsfilecorp.com·4d ago·Neutral

    Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line Vancouver, British Columbia--(Newsfile Corp. - August 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"), has officially commenced commercial production of its highly anticipated new protein-focused product line. This marks a significant milestone in the Company'

    View source ↗